Ridgewood Investments LLC Cuts Position in CME Group Inc (NASDAQ:CME)

Share on StockTwits

Ridgewood Investments LLC lessened its holdings in CME Group Inc (NASDAQ:CME) by 4.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,032 shares of the financial services provider’s stock after selling 53 shares during the quarter. Ridgewood Investments LLC’s holdings in CME Group were worth $207,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in CME. Rampart Investment Management Company LLC grew its holdings in shares of CME Group by 40.9% during the second quarter. Rampart Investment Management Company LLC now owns 4,593 shares of the financial services provider’s stock valued at $892,000 after buying an additional 1,334 shares during the last quarter. ETF Managers Group LLC grew its holdings in shares of CME Group by 25.8% during the second quarter. ETF Managers Group LLC now owns 1,130 shares of the financial services provider’s stock valued at $219,000 after buying an additional 232 shares during the last quarter. Prospera Financial Services Inc grew its holdings in shares of CME Group by 24.0% during the second quarter. Prospera Financial Services Inc now owns 1,646 shares of the financial services provider’s stock valued at $307,000 after buying an additional 319 shares during the last quarter. QCI Asset Management Inc. NY grew its holdings in shares of CME Group by 400.0% during the second quarter. QCI Asset Management Inc. NY now owns 625 shares of the financial services provider’s stock valued at $121,000 after buying an additional 500 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of CME Group by 1.2% during the second quarter. Vanguard Group Inc. now owns 27,992,457 shares of the financial services provider’s stock valued at $5,433,616,000 after buying an additional 328,318 shares during the last quarter. Institutional investors and hedge funds own 84.14% of the company’s stock.

Shares of CME Group stock opened at $205.01 on Thursday. The company has a market cap of $72.95 billion, a price-to-earnings ratio of 30.06, a price-to-earnings-growth ratio of 3.46 and a beta of 0.18. The company’s 50 day moving average is $203.77 and its 200 day moving average is $206.89. CME Group Inc has a twelve month low of $161.05 and a twelve month high of $224.91. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.14.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.15. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The firm’s revenue for the quarter was up 41.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.45 earnings per share. Sell-side analysts expect that CME Group Inc will post 6.81 EPS for the current fiscal year.

The business also recently disclosed a dividend, which was paid on Wednesday, January 15th. Investors of record on Friday, December 27th were given a dividend of $2.50 per share. This is an increase from CME Group’s previous dividend of $1.75. The ex-dividend date was Thursday, December 26th. CME Group’s dividend payout ratio is 43.99%.

In other CME Group news, Director Martin J. Gepsman sold 1,000 shares of the stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $201.16, for a total value of $201,160.00. Following the transaction, the director now directly owns 34,905 shares in the company, valued at $7,021,489.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 39,309 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $202.38, for a total transaction of $7,955,355.42. Following the completion of the transaction, the chief executive officer now owns 46,684 shares in the company, valued at $9,447,907.92. The disclosure for this sale can be found here. Insiders sold 40,609 shares of company stock worth $8,216,221 over the last quarter. Insiders own 1.20% of the company’s stock.

A number of equities research analysts have recently commented on the stock. Citigroup increased their price target on shares of CME Group from $220.00 to $240.00 and gave the company a “buy” rating in a report on Monday, October 21st. JPMorgan Chase & Co. lowered their price objective on shares of CME Group from $183.00 to $173.00 and set an “underweight” rating on the stock in a research report on Friday, December 6th. Deutsche Bank increased their price objective on shares of CME Group from $245.00 to $252.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research report on Friday, January 10th. Finally, Sanford C. Bernstein downgraded shares of CME Group from an “outperform” rating to a “market perform” rating in a research report on Friday, January 10th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $208.36.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Most Active Stocks

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

10 15 Associates Inc. Increases Position in General Mills, Inc.
10 15 Associates Inc. Increases Position in General Mills, Inc.
Blackstone Group LP  Shares Sold by 10 15 Associates Inc.
Blackstone Group LP Shares Sold by 10 15 Associates Inc.
10 15 Associates Inc. Sells 589 Shares of Bank of America Corp
10 15 Associates Inc. Sells 589 Shares of Bank of America Corp
Open Text Corp  Shares Acquired by 10 15 Associates Inc.
Open Text Corp Shares Acquired by 10 15 Associates Inc.
10 15 Associates Inc. Increases Stock Position in SPDR Dow Jones REIT ETF
10 15 Associates Inc. Increases Stock Position in SPDR Dow Jones REIT ETF
10 15 Associates Inc. Grows Holdings in JD.Com Inc
10 15 Associates Inc. Grows Holdings in JD.Com Inc


 
© 2006-2020 Zolmax.